Extracorporeal shock wave therapy versus corticosteroid injection in the treatment of trigger finger: a randomized controlled study

2016 ◽  
Vol 41 (9) ◽  
pp. 977-983 ◽  
Author(s):  
P. Yildirim ◽  
A. Gultekin ◽  
A. Yildirim ◽  
A. Y. Karahan ◽  
F. Tok
Keyword(s):  
Shock Wave ◽  
Corticosteroid Injection ◽  
Extracorporeal Shock Wave Therapy ◽  
Trigger Finger ◽  
Controlled Study ◽  
Shock Wave Therapy ◽  
Level Of Evidence ◽  
Intention To Treat ◽  
Extracorporeal Shock Wave ◽  
Cure Rates

The purpose of this study was to compare the efficacies of extracorporeal shock wave therapy and corticosteroid injection for the management of trigger finger. In this prospective randomized clinical trial, 40 patients with actively correctable trigger fingers were randomly assigned to extracorporeal shock wave therapy (1000 impulses and 2.1 bar) or injection groups. The effectiveness of the treatment was assessed using cure rates, a visual analogue scale, the frequency of triggering, the severity of triggering, the functional impact of triggering, and the Quick-Disabilities of the Arm, Shoulder, and Hand questionnaire at 1, 3, and 6 months after treatment. An intention-to- treat analysis was used in this study. Both groups demonstrated statistically significant improvements in all outcome measures after treatment. The intention-to-treat analyses showed no between-group differences for cure rates, pain, and functional status at follow-up. We conclude that extracorporeal shock wave therapy could be a non-invasive option for treating trigger finger, especially for those patients who wish to avoid steroid injections. Level of evidence: Level II.

Comparison Between Extracorporeal Shock Wave Therapy and Local Corticosteroid Injection for Plantar Fasciitis

2019 ◽  
Vol 41 (2) ◽  
pp. 200-205
Author(s):  
Dingli Xu ◽  
Weiyu Jiang ◽  
Dichao Huang ◽  
Xudong Hu ◽  
Yang Wang ◽  
...  
Keyword(s):  
Shock Wave ◽  
Clinical Outcomes ◽  
Clinical Improvement ◽  
Plantar Fasciitis ◽  
Corticosteroid Injection ◽  
Extracorporeal Shock Wave Therapy ◽  
Controlled Study ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Local Corticosteroid Injection

Background: Extracorporeal shock wave therapy (ESWT) is a nonsurgical treatment for plantar fasciitis (PF) that has had satisfactory clinical outcomes. However, local corticosteroid injection (LCI) is often regarded as first-line treatment of PF, but there have been few studies comparing the 2 methods. Therefore, we compared the effect of ESWT and LCI on patients with PF. Methods: This was a block randomized controlled study comparing 49 patients treated with ESWT and 47 patients treated with LCI from January 2017 to December 2018 who were followed for 6 months. We evaluated the clinical outcomes in the 2 groups, including average pain, first-step pain, plantar fascia thickness, and Foot Function Index, Chinese version of the PF patients. Results: All patients had pain relief and function improvement after treatment, whereas the LCI group did not maintain significant clinical improvement at the 3-month follow-up. The patients in the ESWT group had a significantly better clinical outcome with better duration of improvement than the LCI group. Conclusion: For PF patients, both ESWT and LCI resulted in clinical improvement but EWST provided longer relief than LCI. Level of Evidence: Level II, prospective comparative study.

Effectiveness of Radial Extracorporeal Shock Wave Therapy (rESWT) When Combined With Supervised Exercises in Patients With Subacromial Shoulder Pain: A Double-Masked, Randomized, Sham-Controlled Trial

2017 ◽  
Vol 45 (11) ◽  
pp. 2547-2554 ◽  
Author(s):  
Elisabeth Kvalvaag ◽  
Jens Ivar Brox ◽  
Kaia Beck Engebretsen ◽  
Helene Lundgaard Soberg ◽  
Niels Gunnar Juel ◽  
...  
Keyword(s):  
Shock Wave ◽  
Rotator Cuff ◽  
Shoulder Pain ◽  
Controlled Trial ◽  
Extracorporeal Shock Wave Therapy ◽  
Mean Difference ◽  
Shock Wave Therapy ◽  
Level Of Evidence ◽  
Group Assignment ◽  
Extracorporeal Shock Wave

Background: Subacromial shoulder pain is a common complaint, and radial extracorporeal shock wave therapy (rESWT) is increasingly used to treat this condition. Although many therapists use rESWT in combination with supervised exercises, no studies have evaluated the additional effect of rESWT with supervised exercises for subacromial shoulder pain. Purpose: To assess whether rESWT is more effective than sham rESWT when combined with supervised exercises for improving pain and function in patients with subacromial shoulder pain. Study Design: Randomized controlled trial; Level of evidence, 1. Methods: Patients between 25 and 70 years of age with subacromial shoulder pain with and without calcification in the rotator cuff lasting at least 3 months were assessed for eligibility; 143 patients were recruited. Participants were allocated (1:1) by computer-generated randomization in blocks of 20 to receive either rESWT or sham rESWT in addition to supervised exercises. The rESWT and sham rESWT were performed once a week with additional supervised exercises once a week for the first 4 weeks. The following 8 weeks, the patients received supervised exercises twice a week. The primary outcome was change in the Shoulder Pain and Disability Index (SPADI) after 24 weeks. Patients and outcome assessors were masked to group assignment. Results: At 24 weeks, participants in both the sham group and the rESWT group had improved ( P < .001) in SPADI score compared with baseline (−23.9 points [SD, 23.8 points] and −23.3 points [SD, 25.0 points], respectively), but there were no differences between the groups (mean difference 0.7; 95% CI, −6.9 to 8.3; P = .76). Prespecified subgroup analysis of patients with calcification in rotator cuff showed that the rESWT group had a greater improvement in SPADI score after 24 weeks (mean difference −12.8; 95% CI, −24.8 to −0.8; P = .018). Conclusion: Radial ESWT offered no additional benefit to supervised exercises in the treatment of subacromial shoulder pain after 24 weeks, except in the subgroup of patients with calcification in the rotator cuff. Registration: NCT01441830 ( ClinicalTrials.gov identifier).

Sign in / Sign up

Export Citation Format

Share Document